CLASTEON DIN 02245828
Health Canada record
| Active ingredient(s) | CLODRONATE DISODIUM 400 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M05BA02 CLODRONIC ACID |
| Original market date | 13-May-2004 |
| Current status date | 07-Nov-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Knight Therapeutics Inc. — licence 3-002350, currently licensed, last inspection rating C (2025-11-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CLODRONATE DISODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 01927078 | OSTAC CAP 400MG | HOFFMANN-LA ROCHE LIMITED | Capsule | CLODRONATE DISODIUM 400 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36346 | 2025-11-07 | New Drug Submission (NDS) | Administrative: Change in product ownership |
| 31900 | 2023-10-18 | New Drug Submission (NDS) | Administrative: Manufacturer Name Change |
| 12680 | 2011-10-04 | New Drug Submission (NDS) | Manufacturer Name Change |
| 10160 | 2009-04-17 | New Drug Submission (NDS) | Manufacturer name change |
| 5930 | 2004-12-01 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 366 | 2002-05-01 | New Drug Submission (NDS) | NEW MANUFACTURER AND PRODUCT NAME |
International API supply for CLODRONATE DISODIUM
1 active FDA Drug Master Files.
Request a quote for CLASTEON